[Antihypertensive treatment with cardiotensin. A clinical study (author's transl)].
After an explanation of the treatment of hypertension the results of a clinical study using the combination product Cardiotensin are presented. The results in regard to the components of this product show, that the medicament can be used in hypertension show, that the medicament can be used in hypertension stages I and II and in primary and secondary hypertension especially inthe age of 30--50 years at lower doses without severe side effects.
D000328:Adult; D001581:Benzothiadiazines / Q000627:therapeutic use*; D002046:Bupranolol / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D014223:Triamterene / Q000627:therapeutic use*
D001581:Benzothiadiazines; D004338:Drug Combinations; D011412:Propanolamines; C025276:bemetizide, bupranolol, triamterene drug combination; D002046:Bupranolol; D014223:Triamterene
Antihypertensive Behandlung mit Cardiotensin. Eine klinische Studie.